5,11-Methanomorphanthridine Alkaloids
(3aR,4aS,5R,12R,12aR,13R,13aR)-2,2-Dimethyl-3a,4,4a,6, layer was washed with brine, dried with Na2SO4, and concentrated
12,12a,13,13a-octahydro-5,12-methano[1,3]dioxolo[4Ј,5Ј:4,5]benzo-
under reduced pressure. The residue was used in the next step with-
[1,2-b][1,3]dioxolo[4Ј,5Ј:4,5]benzo[1,2-e]azepin-13-yl Acetate (63): out purification. The residue (12 mg) was heated at reflux with
2,2-Dimethoxypropane (0.1 mL, 0.8 mmol) was added to a solution
of 62 (50 mg, 0.15 mmol), p-TsA (43 mg, 0.22 mmol) and molecular
sieves in dry acetone (0.5 mL) at room temperature, and the pro-
gress of the reaction was monitored by TLC. After completion of
the reaction (6 h), the volatile material was evaporated under re-
duced pressure, and the residue was diluted with CH2Cl2 and
washed with water. The aqueous layer was extracted with CH2Cl2
(3ϫ5 mL), and the combined organic layers were washed with
brine, dried with Na2SO4, and concentrated by rotary evaporation.
The crude product was pure enough to be used in the next step.
freshly distilled DBU (0.04 mL) in dry toluene (0.5 mL) at 110 °C
for 2 d. After completion of the reaction, monitored by analytical
HPLC, the volatile material was evaporated, and the residue was
purified by flash chromatography (CH2Cl2/MeOH, 97:3) to give 65
(8 mg, 89% yield). Rf = 0.4 (CH2Cl2/MeOH, 95:5). IR (CHCl3):
ν
= 2975, 2925, 2853, 1735, 1628, 1480, 1376, 1260, 1041 cm–1.
˜
max
1H NMR (500 MHz, CDCl3): δ = 6.55 (s, 1 H), 6.46 (s, 1 H), 5.87
(ABq, J = 1.5 Hz, 2 H), 5.70 (dd, J = 2.2 Hz, 1 H), 4.48–4.45 (m,
1 H), 4.34 and 3.78 (d, J = 17.0 Hz, 2 H), 4.27 (ddd, J = 11.6, 5.6,
5.6 Hz, 1 H), 3.33–3.30 (m, 1 H), 3.12 (dd, J = 10.8, 2.2 Hz, 1 H),
For analytical data, the product was purified by column 3.08 (m, 1 H), 3.04 (d, J = 10.8 Hz, 1 H), 2.28 (m, 1 H), 1.46 (s, 3
chromatography (CH2Cl2/MeOH, 9:1) to give 63 as a yellow paste
(50 mg, 95%). R = 0.3 (CH Cl /MeOH, 95:5). IR (CHCl ): ν
˜
max
H), 1.35 (s, 3 H),1.32 (m, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 155.6 (C), 146.8 (C), 146.1 (C), 132.4 (C), 124.5 (C), 112.3
f
2
2
3
= 2928, 2857, 1745, 1481, 1374, 1239, 1070 cm–1 1H NMR (CH), 109.5 (C), 107.2 (CH), 106.8 (CH), 100.8 (CH2), 73.9 (CH),
.
(500 MHz, CDCl3): δ = 6.47 (s, 1 H), 6.43 (s, 1 H), 5.86 and 5.85
(ABq, J = 1.2 Hz, 2 H), 5.77 (app. t, J = 1.8 Hz, 1 H), 4.29–4.14
(m, 1 H), 4.19 and 3.75 (ABq, J = 16.5 Hz, 2 H), 3.81 (ddd, J =
2.7, 2.1, 2.0 Hz, 1 H), 3.22 (br. d, J = 10.8 Hz, 1 H), 2.99 (d, J =
11.1 Hz, 1 H), 2.93 (app. t, J = 10.7 Hz, 1 H), 2.87 (br. s, 1 H),
2.48 (m, 1 H), 2.40 (app. dt, J = 10.7, 2.7 Hz, 1 H), 1.51 (s, 3 H),
1.50 (s, 3 H), 1.29 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ
= 169.5 (CO), 146.5 (C), 145.7 (C), 108.6 (CH), 107.0 (CH), 100.8
(CH2), 76.5 (CH), 74.5 (CH), 67.9 (CH), 61.9 (CH2), 59.1 (CH),
59.0 (CH2), 54.6 (CH), 40.1 (CH), 37.0 (CH2), 28.3 (CH3), 26.3
(CH3), 20.4 (CH3) ppm. MS (ESI): m/z = 388.0495 [M + 1]+.
C21H26NO6 (388.44): calcd. C 65.10, H 6.50, N 3.62; found C
65.23, H 6.38, N 3.49.
71.8 (CH), 62.2 (CH), 61.0 (CH2), 55.2 (CH2), 45.4 (CH), 33.2
(CH2), 27.9 (CH3), 25.3 (CH3) ppm. HRMS (EI): calcd. for
C19H21NO4 [M]+ 327.14726; found 327.14706.
(6R,6aS,8R,9S,11S)-5,6a,7,8,9,11-Hexahydro-6,11-methano[1,3]-
dioxolo[4Ј,5Ј:4,5]benzo[1,2-e]benzo[b]azepine-8,9-diol·HCl
(Brunsvigine·HCl, 2·HCl): HCl gas was passed through a solution
of 65 (10 mg, 0.03 mmol) in dry methanol at 0 °C for 15 min. The
reaction mixture was stirred at the same temperature for an ad-
ditional 30 min. The volatile material was evaporated under re-
duced pressure to give the HCl salt of brunsvigine (2) in quantita-
1
tive yield. H NMR (500 MHz, D2O): δ = 6.82 (s, 1 H), 6.71 (s, 1
H), 5.95 and 5.94 (ABq, J = 1.0 Hz, 2 H), 5.95 (m, 1 H), 4.75
merged with the D2O peak, 4.45 (d, J = 15.6 Hz, 1 H), 4.17 (t, J
= 3.9 Hz, 1 H), 4.12–4.09 (m, 1 H), 3.97 (d, J = 2.8 Hz, 1 H), 3.76–
3.71 (m, 1 H), 3.69 (d, J = 11.0 Hz, 1 H), 3.56 (dd, J = 11.0, 2.0 Hz,
1 H), 3.33 (br. s, 1 H), 2.37 (ddd, J = 8.5, 5.2, 3.3 Hz, 1 H), 1.76
(ddd, J = 11.9, 11.9, 11.9 Hz, 1 H) ppm. HRMS (EI): calcd. for
C16H17NO4 287.1158; found 287.11472.
(3aR,4aS,5R,12R,12aR,13R,13aS)-2,2-Dimethyl-3a,4,4a,6,
12,12a,13,13a-octahydro-5,12-methano[1,3]dioxolo[4Ј,5Ј:4,5]benzo-
[1,2-b][1,3]dioxolo[4Ј,5Ј:4,5]benzo[1,2-e]azepin-13-ol (64): NaOMe
(20 mg, 0.77 mmol) was added to a stirred solution of 63 (30 mg,
0.08 mmol) in distilled MeOH (0.5 mL), and the mixture was
stirred at room temp. for 4 h. After completion of the reaction, the
methanol was evaporated, and the residue was redissolved in
CH2Cl2 and washed with water. The aqueous layer was extracted
with CH2Cl2 (3ϫ5 mL), and the combined organic layers were
washed with brine, dried with Na2SO4, and concentrated to give a
white paste, which was purified by silica gel column chromatog-
raphy (CH2Cl2/MeOH, 85:15) to yield pure alcohol 64 as a white
viscous material in 91% yield. Rf = 0.2 (CH2Cl2/MeOH, 9:1). IR
(6R,6aS,8R,9S,11S)-5,6a,7,8,9,11-Hexahydro-6,11-methano[1,3]-
dioxolo[4Ј,5Ј:4,5]benzo[1,2-e]benzo[b]azepine-8,9-diyl Diacetate
(2A): Acetic anhydride (250 μL, 0.210 mmol) was added to a stirred
solution of the HCl salt of brunsvigine (10 mg, 0.028 mmol) and
DMAP (2 mg, 0.016 mmol) in dry pyridine (2 mL) at room temp.,
and the resulting reaction mixture was stirred for 20 h. Pyridine
was evaporated under reduced pressure, and the residue was puri-
fied by chromatography through a silica gel column (CH2Cl2/
MeOH, 97:3) to give 2A in 95% yield as a white crystalline solid.
Rf = 0.4 (CH2Cl2/MeOH, 98:2); m.p. 183–185 °C (ref.[14] 184 °C).
(CHCl ): ν
= 3337, 3018, 2926, 2399, 2360, 2333, 1506, 1485,
˜
3
max
1387, 1240, 1215, 1068 cm–1. 1H NMR (500 MHz, CDCl3): δ =
6.61 (s, 1 H), 6.52 (s, 1 H), 5.92 (ABq, J = 1.4 Hz, 2 H), 4.59 (br.
s, 1 H), 4.30 (m, 1 H), 4.23 and 3.77 (ABq, J = 16.3 Hz, 2 H), 3.95
(d, J = 3.3 Hz, 1 H), 3.30 (d, J = 10.5 Hz, 1 H), 3.04 (d, J =
10.5 Hz, 1 H), 3.05 (br. s, 1 H), 2.52–2.48 (m, 1 H), 2.41–2.38 (m,
1 H), 1.67 (ddd, J = 11.8, 10.5, 10.4 Hz, 1 H), 1.49 (s, 3 H), 1.31
(s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 147.4 (C), 146.8
(C), 130.4 (C), 108.9 (C), 108.0 (CH), 107.0 (CH), 101.2 (CH2),
78.1 (CH), 74.5 (CH), 68.5 (CH), 61.6 (CH2), 58.8 (CH2), 58.1
(CH), 57.0 (CH), 40.4 (CH), 37.2 (CH2), 28.3 (CH3), 26.3 (CH3)
ppm. HRMS (EI): calcd. for C19H23NO5 [M]+ 345.15762; found
345.15728.
IR (neat): ν
= 2932, 2875, 1735, 1528, 1482, 1241, 1048 cm–1.
˜
max
1H NMR (500 MHz, CDCl3): δ = 6.54 (s, 1 H), 6.48 (s, 1 H), 5.89
and 5.86 (ABq, J = 1.2 Hz, 2 H), 5.55 (br. s, 1 H), 5.47 (dd, J =
4.0, 4.0 Hz, 1 H), 4.94 (ddd, J = 12.2, 4.0, 4.0 Hz, 1 H), 4.36 and
3.87 (ABq, J = 16.5 Hz, 1 H), 3.36–3.34 (m, 2 H), 3.09 (ABq, J =
11.0 Hz, 2 H), 3.06 (d, J = 11.0 Hz, 2 H), 2.22–2.20 (m, 1 H), 2.08
(s, 3 H), 2.00 (s, 3 H),1.80 (ddd, J = 11.6, 11.6, 11.6 Hz, 1 H) ppm.
13C NMR (125 MHz, CDCl3): δ = 170.5 (CO), 170.0 (CO), 156.6
(C), 147.0 (C), 146.1 (C), 131.5 (C), 124.5 (C), 112.1 (CH), 107.5
(CH), 106.9 (CH), 100.8 (CH2), 68.8 (CH), 66.1 (CH), 63.0 (CH),
61.2 (CH2), 56.0 (CH2), 45.4 (CH), 30.2 (CH2), 21.0 (CH3), 20.9
(CH3) ppm. HRMS (EI): calcd. for C20H21NO6 [M]+ 371.1369;
found 371.13504.
(3aR,4aS,5R,12S,13aS)-2,2-Dimethyl-3a,4,4a,6,12,13a-hexahydro-
5,12-methano[1,3]dioxolo[4Ј,5Ј:4,5]benzo[1,2-b][1,3]dioxolo[4Ј,5Ј:
4,5]benzo[1,2-e]azepine (65): Mesyl chloride (8 μL, 0.09 mmol) was
added to a stirred solution of 64 (10 mg, 0.03 mmol), DMAP
(2 mg) and TEA (12 μL, 0.09 mmol) in dry CH2Cl2 (1 mL) at 0 °C.
The reaction mixture was stirred at room temp. for 10 h and then
diluted with water (1 mL) and extracted with CH2Cl2. The organic
(4S)-3-{(E)-3-[6-({[2-(1,3-Dioxolan-2-yl)-1-(trimethylsilyl)ethyl][(tri-
methylsilyl)methyl]amino}methyl)-1,3-benzodioxol-5-yl]acryloyl}-
4-benzyloxazolidin-2-one (66): Evans’ acryloyloxazolidinone 67
(2.13 gm, 9.18 mmol) was added to a mixture of K2CO3 (2.53 g,
Eur. J. Org. Chem. 2011, 4571–4587
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4585